0.00Open2.05Pre Close0 Volume155 Open Interest400.00Strike Price0.00Turnover81.43%IV39.97%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry2.05Extrinsic Value100Contract SizeAmericanOptions Type0.0794Delta0.0024Gamma140.12Leverage Ratio-0.1792Theta0.0146Rho11.13Eff Leverage0.1126Vega
Madrigal Pharmaceuticals Stock Discussion
MDGL gained as much as 15.2% to a $294.44 intraday high after Wolfe lauded the company's breakthrough liver drug Rezdiffra, according to published reports.
The U.S. Food and Drug Administration approved Rezdiffra in March as the first treatment fornonalcoholic steatoh...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings(CERE.US)$
$Amicus Therapeutics(FOLD.US)$
$Iovance Biotherapeutics(IOVA.US)$
$Arcellx(ACLX.US)$
$Nuvalent(NUVL.US)$
$Apogee Therapeutics(APGE.US)$
$Inhibrx(INBX.US)$
$Fusion Pharmaceuticals(FUSN.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Vaxcyte(PCVX.US)$
$Soleno Therapeutics(SLNO.US)$
$Medtronic(MDT.US)$
$Madrigal Pharmaceuticals(MDGL.US)$